What is Shanghai Yizhong Pharmaceutical Co., Ltd.'s (688091.SS) StockRank?

MoatMap's StockRank for Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) is 27/100, with a Sell signal. This is a composite score combining Quality (60), Value (15), and Momentum (43) factor ranks across MoatMap's 20,000+ stock universe.

Does Shanghai Yizhong Pharmaceutical Co., Ltd. have an economic moat?

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) has a Quality factor score of 60/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Shanghai Yizhong Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) is Sell, based on a StockRank of 27/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Shanghai Yizhong Pharmaceutical Co., Ltd. in?

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688091.SS

SELLREMOVE

Shanghai Yizhong Pharmaceutical Co., Ltd. · Healthcare · China · $1.4B · Avg Vol: $38M/d

StockRank

P/E (TTM)

119.4x

ROE

4.8%

D/E

0.0x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Shanghai Yizhong Pharmaceutical is a specialized oncology formulation developer. While innovative, it lacks the global scale, diversified pipeline, and manufacturing moat of a leading CDMO partner.

COMPANY DESCRIPTION

Shanghai Yizhong Pharmaceutical Co., Ltd. develops and commercializes innovative drug delivery systems, specializing in polymer micellar formulations for oncology. The company's proprietary nanotechnology platform is highlighted by its approved Paclitaxel Polymeric Micelles for injection, which offers superior efficacy and safety over traditional formulations. It is a high-margin specialty pharmaceutical company focused on advanced formulation technology.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	35M	53M	26M	47M	10.2%
EPS	0.11	0.15	0.00	0.05	-25.1%
Shares	206M	206M	207M	207M	+0.5%
Debt	5M	7M	6M	4M	-10.9%
Equity	195M	216M	208M	211M	2.7%
Op CF	16M	13M	6M	-3M	-40.3%
Inv CF	74M	17M	-28M	-85M	—
Fin CF	-3M	87,449	-17M	-1M	—

PRICE (1M)-29.9%

SMA 50SMA 200

$5.90

RSI (14)

22.8

52W High

$12.36

From 52W High

0.5%

SCORE BREAKDOWN

Quality

ROIC

4.2%54.5

ROE

4.8%55.7

GP/Assets

17.8%41.9

Op. Margin

15.6%75.7

FCF/Assets

-11.1%26.7

Piotroski

—55.8

Int. Cover

50.0x91.4

D/E Ratio

0.02x83.8

Current Ratio

9.48x85.9

Value

P/E (TTM)

119.4x7.5

EV/EBITDA

149.1x1.8

P/FCF

—N/A

P/B

5.7x20.5

P/S

25.9x14.2

Div Yield

—N/A

Momentum

52W High %

48%21.1

RS 6M

-22%53.5

SMA 50/200

0.99x59.7

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—N/A

Q Growth

28%67.9

FUNDAMENTALS

Market Cap

$1.4B

P/E (Forward)

—

Gross Margin

83.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688091.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688091.SS	Shanghai Yizhong Pharmaceutical Co., Ltd.(you)	$1.4B	27	SELL
300363.SZ	Porton Pharma Solutions Ltd.	$1.2B	26	SELL
600252.SS	Guangxi Wuzhou Zhongheng Group Co., Ltd	$1.0B	29	SELL
002099.SZ	Zhejiang Hisoar Pharmaceutical Co., Ltd.	$1.3B	21	SELL
603567.SS	Heilongjiang ZBD Pharmaceutical Co., Ltd.	$994M	26	SELL
600129.SS	Chongqing Taiji Industry(Group) Co.,Ltd	$1.2B	23	SELL
002940.SZ	Zhejiang AngLiKang Pharmaceutical CO.,LTD.	$1.0B	25	SELL
300702.SZ	Zhejiang Tianyu Pharmaceutical Co., Ltd.	$989M	26	SELL
002038.SZ	Beijing SL Pharmaceutical Co., Ltd.	$893M	28	SELL
688176.SS	Jiangsu Yahong Meditech Co., Ltd.	$961M	30	SELL

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.0%

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) — Stock Score Summary

Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) has a MoatMap StockRank of 27/100 based on Quality (60/100), Value (15/100), and Momentum (43/100) factor scores. The current signal is SELL. Shanghai Yizhong Pharmaceutical is a specialized oncology formulation developer. While innovative, it lacks the global scale, diversified pipeline, and manufacturing moat of a leading CDMO partner.

Key Financial Metrics

Price	$5.90
Market Cap	$1.4B
P/E (TTM)	119.38
Price/Book	5.74
Return on Equity	4.8%
Return on Invested Capital	4.2%
Debt/Equity	1.73
Gross Margin	83.6%
Operating Margin	15.6%
Revenue Growth	11.4%
Free Cash Flow	$-4M

Shanghai Yizhong Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shanghai Yizhong Pharmaceutical Co., Ltd.’s (688091.SS) StockRank?: MoatMap’s StockRank for Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) is 27/100, with a Sell signal. It is a composite of Quality (60), Value (15), and Momentum (43) factor ranks across MoatMap’s 20,000+ stock universe.
Does Shanghai Yizhong Pharmaceutical Co., Ltd. have an economic moat?: Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) has a Quality factor score of 60/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shanghai Yizhong Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) is Sell, based on a StockRank of 27/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shanghai Yizhong Pharmaceutical Co., Ltd. in?: Shanghai Yizhong Pharmaceutical Co., Ltd. (688091.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).